OFI Invest Asset Management Grows Holdings in Humana Inc. (NYSE:HUM)

OFI Invest Asset Management boosted its holdings in Humana Inc. (NYSE:HUM) by 20.7% in the second quarter, HoldingsChannel reports. The institutional investor owned 251 shares of the insurance provider’s stock after purchasing an additional 43 shares during the quarter. OFI Invest Asset Management’s holdings in Humana were worth $88,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Harrell Investment Partners LLC purchased a new stake in Humana in the second quarter worth $210,000. Everpar Advisors LLC lifted its stake in shares of Humana by 34.9% during the 2nd quarter. Everpar Advisors LLC now owns 866 shares of the insurance provider’s stock worth $324,000 after purchasing an additional 224 shares during the last quarter. Blue Trust Inc. raised its stake in shares of Humana by 51.7% during the 2nd quarter. Blue Trust Inc. now owns 1,708 shares of the insurance provider’s stock worth $592,000 after acquiring an additional 582 shares in the last quarter. Baader Bank Aktiengesellschaft boosted its stake in Humana by 1.0% in the 2nd quarter. Baader Bank Aktiengesellschaft now owns 4,421 shares of the insurance provider’s stock worth $1,649,000 after purchasing an additional 42 shares in the last quarter. Finally, 180 Wealth Advisors LLC lifted its position in Humana by 13.0% during the 2nd quarter. 180 Wealth Advisors LLC now owns 1,156 shares of the insurance provider’s stock worth $439,000 after acquiring an additional 133 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Truist Financial raised their target price on shares of Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a report on Monday, July 15th. Royal Bank of Canada decreased their price objective on shares of Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a report on Thursday, April 25th. Cantor Fitzgerald restated a “neutral” rating and set a $360.00 price target on shares of Humana in a research report on Tuesday, July 23rd. Deutsche Bank Aktiengesellschaft increased their target price on Humana from $341.00 to $349.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, Bank of America increased their price objective on Humana from $342.00 to $376.00 and gave the company a “neutral” rating in a research note on Monday, May 20th. Thirteen analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $403.55.

Humana Price Performance

Humana stock opened at $350.36 on Monday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.67 and a current ratio of 1.66. Humana Inc. has a one year low of $298.61 and a one year high of $530.54. The business has a fifty day moving average of $367.60 and a two-hundred day moving average of $346.43. The company has a market cap of $42.22 billion, a P/E ratio of 21.82, a price-to-earnings-growth ratio of 2.09 and a beta of 0.51.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. The company had revenue of $29.54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period last year, the company posted $8.94 earnings per share. As a group, analysts predict that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be issued a dividend of $0.885 per share. The ex-dividend date is Monday, September 30th. This represents a $3.54 annualized dividend and a yield of 1.01%. Humana’s dividend payout ratio is presently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.